DIVISLAB

HealthcareDrug Manufacturers - Specialty & GenericLarge Cap
Divi's Laboratories Limited

Divi's Laboratories Limited manufactures and sells generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals. The company also provides custom synthesis c...

हिन्दी में

Divi's Laboratories Limited जेनेरिक एक्टिव फार्मास्युटिकल इंग्रेडिएंट्स (APIs), इंटरमीडिएट्स और न्यूट्रास्यूटिकल्स का निर्माण और बिक्री करती है। कंपनी APIs और इंटरमीडिएट्स के लिए क...

₹9,340-0.22%1D
Previous trading day close · Data updates after market close
1W: +1.6%
1M: -1.6%
6M: +52.7%
1Y: +60.3%
65/100
AverageResearch Score
Market Cap
₹1.78L Cr
Large Cap
P/E Ratio
69.85
Premium
P/B Ratio
11.98
Premium
ROE
15.4%
Decent
ROCE
22.1%
Excellent
Debt / Equity
0.00
Low debt
Div. Yield
0.4%
EV/EBITDA
45.34
Expensive
52W Low: ₹5,647.5Current: ₹9,34052W High: ₹9,740
At 90% of 52-week range
Data as of previous trading day close · Updated after market close
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated after market close
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
85/100
Growth
Revenue, EPS, profit growth
72/100
Valuation
PE, PB, EV/EBITDA vs sector
15/100
Risk
Debt levels, volatility, coverage
89/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
69.85(Premium)
Forward P/E
60.00(Premium)
P/B Ratio
11.98(Premium)
P/S Ratio
16.21(Expensive)
EV/EBITDA
45.34(Expensive)
Dividend Yield
0.4%
5Y CAGR
8.4%(Moderate)
Revenue Growth
14.0%(Moderate)
Profitability
ROE
15.4%(Good)
ROCE
22.1%(Excellent)
ROA
13.5%(Efficient)
Net Margin
23.2%(High)
EBITDA Margin
35.0%
Financial Health
Debt to Equity
0.00(Low debt)
Current Ratio
6.94(Healthy)
Quick Ratio
4.71(Good)
Interest Coverage
148.30x(Comfortable)
Technical Indicators
Based on previous trading day close
RSI (14)
49(Neutral)
RSI Exp (14)
37(Neutral)
MACD
119.884(Bullish)
MACD Signal
167.975
BB Position
40%(Middle)
BB Width
6.31%(Normal)
ADX (14)
14.1(Sideways)
Williams %R
-60.4(Neutral)
MFI (14)
37(Neutral)
CCI (20)
-24(Neutral)
Stoch %K
40(Neutral)
ATR (14)
208.39(Avg True Range)
OBV (M)
28.0(Positive)
1W OBV Chg
-1.5%(Decreasing)
Rel Volume
0.75x(Normal)
Volatility
25.9%(Moderate)
Max DD 1Y
-18.5%(Resilient)
EMA 200
7529.6
EMA 50
8906.0
SMA 200
7117.5
vs SMA 50
3.7%(Above SMA50)
vs SMA 200
31.2%(Above SMA200)
Volume
3.79L
Avg Vol 3M
5.0L
Shareholding Pattern
Promoter
51.9%
High confidence
FII
20.3%
Strong foreign interest
DII / MF
19.2%
Strong MF interest
Share DIVISLAB
Share this stock analysis with your network
𝕏 Share on XWhatsAppLinkedIn
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates after market close. Please consult a SEBI-registered advisor before investing.